Can diet help people with type 1 diabetes lose weight? new study aims to find out

NCT ID NCT07667504

Recruiting now Disease control Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This study compares three diets for weight loss in adults with type 1 diabetes who are overweight or obese. Participants will follow either a moderate carbohydrate restriction, an early time-restricted eating plan, or a standard calorie-restricted diet. The goal is to see which approach works best and is safe for managing weight in this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dietary interventions (moderate carbohydrate restriction, early time-restricted eating, standard calorie restriction)
What this could lead to: If successful, this could provide safe and effective dietary strategies for weight loss in people with type 1 diabetes, helping reduce complications.
What could go wrong: This is a small early-stage trial with only 75 participants, so results may not apply to everyone. Dietary changes can be hard to follow long-term, and weight loss might not be sustained.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY & OVERWEIGHT TYPE 1 DIABETES (T1D)

Contacts and locations

Locations

Virgen de la Victoria University Hospital
RECRUITING

Málaga, Málaga, 29010, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.